Correlation Between Biofrontera Warrants and Omega Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biofrontera Warrants and Omega Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofrontera Warrants and Omega Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biofrontera Warrants and Omega Therapeutics, you can compare the effects of market volatilities on Biofrontera Warrants and Omega Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofrontera Warrants with a short position of Omega Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofrontera Warrants and Omega Therapeutics.

Diversification Opportunities for Biofrontera Warrants and Omega Therapeutics

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Biofrontera and Omega is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Biofrontera Warrants and Omega Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Omega Therapeutics and Biofrontera Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofrontera Warrants are associated (or correlated) with Omega Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Omega Therapeutics has no effect on the direction of Biofrontera Warrants i.e., Biofrontera Warrants and Omega Therapeutics go up and down completely randomly.

Pair Corralation between Biofrontera Warrants and Omega Therapeutics

Assuming the 90 days horizon Biofrontera Warrants is expected to generate 5.24 times more return on investment than Omega Therapeutics. However, Biofrontera Warrants is 5.24 times more volatile than Omega Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Omega Therapeutics is currently generating about -0.3 per unit of risk. If you would invest  19.00  in Biofrontera Warrants on August 31, 2024 and sell it today you would lose (11.11) from holding Biofrontera Warrants or give up 58.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy90.91%
ValuesDaily Returns

Biofrontera Warrants  vs.  Omega Therapeutics

 Performance 
       Timeline  
Biofrontera Warrants 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Biofrontera Warrants are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady forward indicators, Biofrontera Warrants showed solid returns over the last few months and may actually be approaching a breakup point.
Omega Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Omega Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Biofrontera Warrants and Omega Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biofrontera Warrants and Omega Therapeutics

The main advantage of trading using opposite Biofrontera Warrants and Omega Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofrontera Warrants position performs unexpectedly, Omega Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omega Therapeutics will offset losses from the drop in Omega Therapeutics' long position.
The idea behind Biofrontera Warrants and Omega Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years